One of the most well-known examples of a helpful mutation is lactose tolerance, a single genetic change that allows about 35% of adults worldwide to digest milk throughout their lives. But it’s far from the only one. Humans carry several mutations that provide real survival advantages, from resisting deadly infections to lowering the risk of heart disease. Here are the most striking examples and how they work.
Lactose Tolerance: Digesting Milk as an Adult
Most mammals lose the ability to digest milk after infancy. The gene that produces lactase, the enzyme that breaks down milk sugar, naturally shuts down as you grow up. In most of the world’s population, this is still the default. About 75% of people in Europe can digest lactose, but intolerance rates climb to 50-80% among Hispanic, South Asian, and Black populations, and reach nearly 100% in East Asian and Native American populations.
The mutation behind lactose tolerance doesn’t actually sit in the lactase gene itself. It’s located in a nearby stretch of DNA that acts as a dimmer switch, controlling how much lactase your body makes. In people with the mutation, this switch creates a new binding site for a protein that keeps the lactase gene turned on into adulthood. Instead of production winding down after weaning, it just keeps going. The most common version of this mutation has nearly reached fixation in parts of Northern Europe, meaning almost everyone there carries it. It arose and spread in populations that relied heavily on dairy farming, giving those individuals a significant caloric advantage.
Sickle Cell Trait: Protection Against Malaria
Sickle cell disease is devastating when a person inherits two copies of the mutated hemoglobin gene. But carrying just one copy, known as sickle cell trait, provides substantial protection against the deadliest form of malaria. This is why the mutation persists at high frequencies in West Africa, the Mediterranean, and parts of South Asia, all regions where malaria has historically been a major killer.
The protection works through several mechanisms. Red blood cells carrying the sickle hemoglobin are harder for the malaria parasite to thrive in. When a parasite does infect these cells, the cells tend to sickle more readily than uninfected ones, which flags them for removal by the immune system’s cleanup crew. Children with sickle cell trait also show a significant delay in their first malaria episode, roughly 34 days longer than children without the trait, and they develop stronger immune responses against the proteins the parasite uses to hide from the immune system. Studies in West African populations found that the sickle cell carrier state was negatively associated with all major forms of severe malaria, including cerebral malaria, one of the most common causes of death from the disease.
CCR5-Delta32: Built-In HIV Resistance
HIV enters immune cells by latching onto a surface protein called CCR5, which normally serves as a docking point for chemical signals in the immune system. A mutation called CCR5-delta32 deletes 32 base pairs from the gene that codes for this protein, resulting in a shortened, nonfunctional version that never reaches the cell surface. People who inherit two copies of this deletion essentially lack the doorway HIV uses to get inside their cells, making them highly resistant to infection.
This mutation is most common in people of Northern European descent. It gained widespread attention after a handful of HIV-positive patients were functionally cured through bone marrow transplants from donors carrying two copies of the deletion. People with just one copy still produce some functional CCR5, so they aren’t fully resistant, but they tend to progress more slowly if infected.
Low Cholesterol: A Mutation That Prevents Heart Disease
Some people carry loss-of-function mutations in a gene called PCSK9, which normally limits how efficiently your liver clears LDL cholesterol from your blood. When this gene is partially or fully disabled, your liver becomes exceptionally good at pulling LDL out of circulation. In the Atherosclerosis Risk in Communities study, individuals with these mutations had LDL cholesterol levels 28% lower than average and an 88% reduction in major coronary events over 15 years. That’s not a modest benefit. It’s a near-elimination of heart attack risk, conferred by a single genetic change present from birth.
This discovery was so striking that it directly inspired an entire class of cholesterol-lowering drugs designed to mimic the effect of these natural mutations.
High Altitude Adaptation in Tibetans
Tibetans have lived at elevations above 4,000 meters for thousands of years, where oxygen levels are roughly 40% lower than at sea level. Most people who move to these altitudes compensate by producing far more red blood cells, which thickens the blood and raises the risk of stroke, blood clots, and a condition called chronic mountain sickness. Tibetans don’t do this. Their hemoglobin levels stay relatively low, and chronic mountain sickness is rare among them.
The key mutation sits in a gene called EPAS1, which encodes a protein involved in the body’s oxygen-sensing system. Variants in this gene appear to dampen the normal response to low oxygen, preventing the overproduction of red blood cells that causes so many problems at altitude. These variants exist at high frequency only in high-altitude populations and are strongly associated with the lower hemoglobin concentrations seen in Tibetans. The mutation also appears to reduce susceptibility to high-altitude pulmonary edema, a dangerous fluid buildup in the lungs that affects many lowlanders who ascend too quickly.
APOE2: A Shield Against Alzheimer’s
The APOE gene comes in three common versions: e2, e3, and e4. The e3 variant is considered neutral, and e4 is the most well-known genetic risk factor for Alzheimer’s disease. The e2 variant, however, is powerfully protective. According to research from the National Institute on Aging using autopsy-confirmed cases, people with two copies of e2 had an 87% lower risk of Alzheimer’s compared to people with two copies of the common e3 variant, and a 99.6% risk reduction compared to those with two copies of e4.
APOE2 is relatively rare in the general population, which is part of why its protective effect took longer to quantify. But the scale of the protection is remarkable, particularly for a single gene variant influencing a disease as complex as Alzheimer’s.
Extra-Dense Bones: The LRP5 Mutation
A family first identified in the 1990s carried an unusual trait: extraordinarily dense bones that appeared virtually unbreakable. The cause was a single amino acid change in a gene called LRP5, where one building block (glycine) was swapped for another (valine) at a specific position. This mutation supercharges a signaling pathway that controls bone formation. In affected family members, markers of bone building were markedly elevated while bone breakdown proceeded at a normal rate, meaning their skeletons were constantly adding density without the usual counterbalance.
The visible effects included a thickened jawbone and bony growths on the roof of the mouth. While these features are cosmetically noticeable, the carriers experienced no fractures and no pain. The mutation essentially does the opposite of osteoporosis, making bones denser over a lifetime instead of weaker. Understanding this pathway has influenced research into treatments for osteoporosis and other conditions involving bone loss.
Why Helpful Mutations Spread
A beneficial mutation doesn’t guarantee success. When a new mutation first appears, it exists in a single individual, and random chance alone could easily eliminate it in the next generation. Even a mutation that boosts survival has only a small probability of becoming permanent in a population. The odds improve when the survival pressure is intense and persistent: malaria killing children before reproductive age, famine selecting for those who can extract calories from milk, or low oxygen slowly wearing down anyone without the right hemoglobin response.
What all these examples share is that they solve a specific environmental problem. Lactose tolerance is only useful where dairy farming exists. Sickle cell trait is only advantageous where malaria is endemic. The same mutation that helps in one context can be neutral or even harmful in another, which is why beneficial mutations tend to cluster in populations that faced the relevant pressure for generations.